Miami CTSI

E-mail a Friend

Research Feasibility

The following types of proposals will be reviewed for feasibility prior to study intake. Please review the steps to submitting a feasibility intake form.

Industry-Sponsored Clinical Research Studies

Beginning September 1, 2022, all new industry-sponsored clinical research studies, will be reviewed for feasibility by the Miller School of Medicine (MSOM) Research Feasibility Committee (RFC) prior to IRB submission.

This process will optimize the allocation of institutional resources and effort, while improving the overall performance of clinical research at the Miller School of Medicine.

What do I need to do?
Study teams will be required to complete the Feasibility Intake Form for all new, industry-sponsored clinical research studies, prior to IRB submission and ORA contracting.

Who do I contact with questions?
If you have any questions, please feel free to contact the Committee at msomfeasibility@med.miami.edu.

Additional Information
Research Committee Process and Timeline

Resources
Videos on Research Feasibility Assessment Tools
For more information, including training videos on how to perform a feasibility check/query/analysis using programs like URIDE or Epic SlicerDicer, click on the link for the Research Feasibility Assessment Tools. First time users will need to register for an account with your University of Miami email address. Once registered and/or logged in, click “Enroll Me” to view the video and PowerPoint training materials for how to use these feasibility tools.




Member Department/Division 
Maria L. Alcaide, MD (Chair) Medicine/Infectious Diseases 
Carl Schulman, MD, PhD (Co-Chair) Surgery/Burn 
Maria T. Abreu, MD Medicine/Gastroenterology  
Barbara J. Coffey, MD Psychiatry 
Stephen D. Nimer, MD Hematology 
Patrizio Pasquale, MD Obstetrics and Gynecology 
Vittorio Porciatti, DSc Ophthalmology 
JoNell E. Potter, PhD Obstetrics and Gynecology/Reproductive Sciences 
Sanoj Punnen, MD Urology 
David Reis, PhD UHealth IT 

COVID-19 Feasibility

All investigators interested in conducting a COVID-19 related study must complete the COVID-19 study intake form before submitting the study to the HSRO and ORA.

The Feasibility Committee is made up of scientific and clinical experts at the Miller School of Medicine. The committee’s charge is to assess which studies have the best chance of benefiting current and future patients with the goal of improving the quality of research and to ensure that there are not duplicative studies with the same participant population. Investigators will be notified of the Committee’s decision and recommendation.

If you have any questions regarding the new COVID-19 Feasibility Committee, please email clinicalresearch@miami.edu.

The Office of the Executive Dean for Research and Miami CTSI support this schoolwide COVID-19 Feasibility Committee led by Maria Abreu, M.D., Vice Chair for Research in the Department of Medicine.



Member Department/Division 
Maria Abreu, MD (CHAIRMedicine/Gastroenterology 
Jose Castro, MD Medicine/Infectious Diseases 
Susanne Doblecki-Lewis, MD Medicine/Infectious Diseases 
Elizabeth Franzmann, MD Otolaryngology/Head and Neck 
Hayley Gershengorn, MD Medicine/Pulmonary 
Richard A. Preston, MD Medicine/Clinical Pharmacology 
Richard Silverman, MD Anesthesiology/Critical Care Medicine 
Adam Wanner, MD Medicine/Pulmonary 

E-mail a Friend